Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)

The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.

NCT Number	NCT06626386
Lead Sponsor	Heinrich-Heine University, Duesseldorf
Conditions	Prostate Cancer
Enrollment	200 participants
Start Date	2024-06-01
Primary Completion	2024-09-30 (estimated)
Study Completion	2024-10-31 (estimated)
Updated on ClinicalTrials.gov	2024-10-03